Veradigm ™ Supports Cancer Experience Registry With Targeted Outreach Direct to Oncology Healthcare Professionals
Veradigm™, an Allscripts (NASDAQ:MDRX), business unit and a leader in providing next-generation healthcare data solutions and systems, is leveraging its capability to communicate directly with a broad network of ambulatory healthcare professionals (HCPs) in order to increase public awareness and access to the Cancer Experience Registry. (Source: eHealth News EU)
Source: eHealth News EU - February 6, 2019 Category: Information Technology Tags: Featured Allscripts Business and Industry Source Type: news

Merck to expand US biopharmaceutical R & D facility to advance innovative clinical pipeline
Merck, a leading science and technology company, today announced a $70 million investment to expand its state of the art research and development (R&D) facility in Billerica, Massachusetts. The new building will span 145,000 square feet, offering new laboratory and collaborative working space to accommodate approximately 400 new and current R&D employees focused on advancing science in oncology, immuno-oncology and immunology. (Source: World Pharma News)
Source: World Pharma News - February 6, 2019 Category: Pharmaceuticals Tags: Featured Merck Group Business and Industry Source Type: news

Too Much TV Raises Women's Odds for Early-Onset Colon Cancer: Study
Title: Too Much TV Raises Women's Odds for Early-Onset Colon Cancer: StudyCategory: Health NewsCreated: 2/5/2019 12:00:00 AMLast Editorial Review: 2/6/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 6, 2019 Category: Cancer & Oncology Source Type: news

AI can predict breast cancer molecular subtypes on MRI
Can an artificial intelligence (AI) algorithm identify the molecular subtype...Read more on AuntMinnie.comRelated Reading: Russian AI detects lung cancer on CT in 20 seconds AI can detect, localize fractures on wrist x-rays AI reveals cause of transient ischemic attack symptoms Breast MRI effective as adjunct to DBT in high-risk women AI uses features outside nodules to predict malignancy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 6, 2019 Category: Radiology Source Type: news

Carbon-11 PET detects brain inflammation after Lyme disease
Researchers at Johns Hopkins Medicine have developed a PET imaging technique...Read more on AuntMinnie.comRelated Reading: PET's view of tau could explain women's early dementia PET in the paddock New PET tracer could aid melanoma detection PET tracers help guide breast cancer therapies C-11-based PET tracer could benefit arthritis patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 6, 2019 Category: Radiology Source Type: news

Researchers reveal prostate tumors 'fed' by fatty acids
(University of Melbourne) An international multidisciplinary study initiated by Melbourne scientists has shown a link between prostate cancer and the uptake of fatty acids by cancer cells. The findings point to a possible therapeutic target for this common cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 6, 2019 Category: Cancer & Oncology Source Type: news

Japanese study finds concerning trends in cervical cancer and treatment response
(Osaka University) Osaka University-centered research examined a large-scale Japanese data cohort for trends in cervical cancer prevalence, treatment, and survival. They identified a troubling increase in age-adjusted prevalence, especially among younger people. Japan is the only advanced economy to show such an increase. Additionally, and interestingly, the research found that, in localized cervical cancer, younger people had worse survival rates than older patients when undergoing radiation. The findings are useful for informing preventive measures and treatment choices. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 6, 2019 Category: Cancer & Oncology Source Type: news

Oncologists Seek Education on Health Needs of LGBTQ Patients
A recent study showed oncologists lack knowledge, but are interested in receiving additional training to learn about the healthcare needs of LGBTQ patients. (Source: CancerNetwork)
Source: CancerNetwork - February 6, 2019 Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news

UNC-led team awarded $5.1 million for cervical cancer prevention in Malawi
(UNC Lineberger Comprehensive Cancer Center) The United States Agency for International Development, in partnership with the US National Academies of Science, Engineering, and Medicine, will fund two new programs to prevent cervical cancer in sub-Saharan Africa, including a project led by UNC scientists and physicians in Malawi. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2019 Category: International Medicine & Public Health Source Type: news

Study Investigates Diverse Molecular Mechanisms Driving Treatment Resistance in AML
Researchers evaluated  the primary mechanisms governing drug resistance and relapse in patients treated with crenolanib, an FLT3 inhibitor. (Source: CancerNetwork)
Source: CancerNetwork - February 6, 2019 Category: Cancer & Oncology Authors: John Schieszer Source Type: news

Discovery may bolster chemotherapy potency while protecting the heart from side-effects
(University of Alberta Faculty of Medicine& Dentistry) Researchers from the University of Alberta may have found a way to make chemotherapy more effective at treating cancer while blocking its harmful side-effects on the heart. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 6, 2019 Category: Cancer & Oncology Source Type: news

Escort service: The role of immune cells in the formation of metastases
(University of Basel) Tumor cells use a certain type of immune cells, the so-called neutrophils, to enhance their ability to form metastases. Scientists have deciphered the mechanisms of this collaboration and found strategies for blocking them. This is reported by researchers from the University of Basel and the University Hospital of Basel in the scientific journal Nature. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 6, 2019 Category: Cancer & Oncology Source Type: news

Nullifying protein YTHDF1 enhances anti-tumor response
(University of Chicago Medical Center) Identifying molecular pathways that boost the immune response to tumor neoantigens opens up new ways to develop and amplify cancer immunotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 6, 2019 Category: Cancer & Oncology Source Type: news

A hidden route for fatty acids can make cancers resistant to therapy
(VIB (the Flanders Institute for Biotechnology)) Researchers from the lab of Prof. Sarah-Maria Fendt at the VIB-KU Leuven Center for Cancer Biology now demonstrate that certain tumor cells use an alternative -- previously unexplored -- pathway to produce fatty acids. This finding can explain the resistance of particular cancer types to fatty acid metabolism inhibition. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 6, 2019 Category: Cancer & Oncology Source Type: news

NETRF announces $2.5 million in research to advance the treatment of rare cancer
(Neuroendocrine Tumor Research Foundation) The Neuroendocrine Tumor Research Foundation (NETRF) continues its aggressive funding of neuroendocrine cancer research with eight new grants totaling $2.5 million. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 6, 2019 Category: Cancer & Oncology Source Type: news

More physical than chemical: Researchers show what really gets cells going
(Osaka University) Collective cell migration is essential in many organisms, with roles in human cellular processes including cancer invasion and wound healing. Now, a team led by researchers at Osaka University have found that traditional thinking regarding the role of chemical signalling in collective cell migration may not hold true. The researchers found that in the later stages of development of a model unicellular amoeba, cell-to-cell contact rather than cAMP signalling is likely to trigger cell motility. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2019 Category: International Medicine & Public Health Source Type: news

Keep up-to-date with the latest developments in anti-obesity medications
(Bentham Science Publishers) The fourth volume of this series covers six reviews on anti-obesity treatment strategies including updates on obesity and Cancer prevention through dietary modulation, the role of anti-obesity medications in polycystic ovary syndrome, potential anti-obesity strategies targeting mitochondria, calcium silicate based formulations for anti-obesity therapy, and the identification of obesity medications from natural products and plants. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2019 Category: International Medicine & Public Health Source Type: news

Combination treatment, diabetes drug and immunotherapy, may help to fight breast cancer
(University of Helsinki) Researchers in Finland have discovered a drug combination that collaborates with the cancer cells' own MYC oncoprotein, which in large quantities causes self-destruction of the cancer cells. When this combination is enhanced with immune system-boosting anti-PD-1 therapy, a more effective and long-lasting therapeutic effect can be seen in mice. These findings pave the way for new treatment combination strategies to harness the body's natural defenses to fight cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 6, 2019 Category: Cancer & Oncology Source Type: news

Financial relationships and prescribing practices between physicians and drug companies
(Wiley) In a study published in The Oncologist, physicians treating certain cancers who consistently received payments from a cancer drug's manufacturer were more likely to prescribe that drug over alternative treatments. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2019 Category: International Medicine & Public Health Source Type: news

Greater efforts needed to address cancer therapies' effects on bone health
(Wiley) A new British Journal of Clinical Pharmacology review examines the impact of cancer therapies on the skeleton and how to limit bone loss and fractures in cancer patients treated with these therapies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2019 Category: International Medicine & Public Health Source Type: news

Study examines race-based differences in social support needs among breast cancer patients
(Wiley) In a Psycho-Oncology study of 28 women who were being treated for breast cancer and were participating in focus groups, White participants noted that having other breast cancer survivors in their support network was essential for meeting their social support needs. Black participants did not reference other breast cancer survivors as part of their networks, however. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2019 Category: International Medicine & Public Health Source Type: news

Prostate cancer: UK hospital urges men to get PSA test to detect symptoms of the disease
PROSTATE cancer is the most common cancer among men in the UK, and now a Surrey-based hospital is urging men in the country to make a New Year ’s Resolution to get a PSA test to detect possible symptoms of the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - February 6, 2019 Category: Consumer Health News Source Type: news

Research confirms the healing potential of monk fruit on cancer patients
(Natural News) Monk fruit (Siraitia grosvenorii) is one of the stalwarts of traditional Chinese medicine that found new uses in modern times. Many studies are now confirming its therapeutic effectiveness against certain types of cancer. In the West, the fruit serves as an alternative sweetener that is much healthier than processed sugar. It is believed to decrease bad cholesterol and alleviate the symptoms... (Source: NaturalNews.com)
Source: NaturalNews.com - February 6, 2019 Category: Consumer Health News Source Type: news

Research proves the healing potential of monk fruit on cancer patients
(Natural News) Monk fruit (Siraitia grosvenorii) is one of the stalwarts of traditional Chinese medicine that found new uses in modern times. Many studies are now confirming its therapeutic effectiveness against certain types of cancer. In the West, the fruit serves as an alternative sweetener that is much healthier than processed sugar. It is believed to decrease bad cholesterol and alleviate the symptoms... (Source: NaturalNews.com)
Source: NaturalNews.com - February 6, 2019 Category: Consumer Health News Source Type: news

Add-On Cyramza Flops in First-Line Gastric Cancer Trial
(MedPage Today) -- No improvement in progression-free or overall survival (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 6, 2019 Category: Hematology Source Type: news

Fertility Treatments Don't Raise Cancer Risk for Offspring
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - February 6, 2019 Category: Cancer & Oncology Source Type: news

Benign Ovarian Cysts Should Be Left in Place, Study Suggests
(Source: Cancercompass News: Gynecological Cancer)
Source: Cancercompass News: Gynecological Cancer - February 6, 2019 Category: Cancer & Oncology Source Type: news

Bowel cancer screening tests exceed target set in Scotland
Simpler test thought to have contributed to figures Related items fromOnMedica New test prompts rise in bowel screening uptake Invest in workforce to roll out bowel cancer screening, urges former health secretary Cancer strategies failed to improve one-year survival Faecal blood testing best to spot cancer and cost-effective Obesity as cause of cancer set to overtake smoking (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 6, 2019 Category: UK Health Source Type: news

Preschool teacher, 30, thriving after being given one week to live with rare brain tumor
Amanda Thomas, 30, from Charlotte, North Carolina, was diagnosed with a rare, aggressive brain cancer in November 2017 and was told she was not a candidate for surgery or chemotherapy. (Source: the Mail online | Health)
Source: the Mail online | Health - February 5, 2019 Category: Consumer Health News Source Type: news

Cancer symptoms: Four signs you need to know to boost chances of survival
CANCER symptoms can be mistaken for much less serious health conditions, but failing to recognise the disease can significantly slash your chances of survival. Some signs are more easily recognisable than others - here are four you could overlook. (Source: Daily Express - Health)
Source: Daily Express - Health - February 5, 2019 Category: Consumer Health News Source Type: news

Watching TV could give you BOWEL CANCER: An hour a day is enough to increase young people's risk
Study looked at sedentary behaviours of 90,000 women. Researcher Dr Yin Cao from Washington University School of Medicine said younger people may benefit from screening. (Source: the Mail online | Health)
Source: the Mail online | Health - February 5, 2019 Category: Consumer Health News Source Type: news

New European Rules to Eliminate Carcinogens in Sartans New European Rules to Eliminate Carcinogens in Sartans
The Committee for Medicinal Products for Human Use recommends new requirements for manufacturing to eliminate nitrosamine impurities, giving a'worst case'estimate of the associated cancer risk.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 5, 2019 Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news

UCLA ’s Dennis Slamon awarded Sjöberg Prize for pioneering cancer research
Dr. Dennis Slamon, director of the Revlon/UCLA Women ’s Cancer Research Program, has been named a co-winner of the 2019 Sjöberg Prize by the Royal Swedish Academy of Sciences and Sweden’s Sjöberg Foundation. Honored for his groundbreaking research that led to the development of successful targeted cancer therapies, Slamon shares the award with D r. Brian Druker of Oregon Health& Science University.The Sj öberg Prize has been awarded annually since 2016 to recognize outstanding cancer research. The honor carries a prize of $1 million — $100,000 as award money and $900,000 to fund future ...
Source: UCLA Newsroom: Health Sciences - February 5, 2019 Category: Universities & Medical Training Source Type: news

Study: Self-Compression OK in Mammography
(MedPage Today) -- Noninferior to standard compression in randomized trial, with less pain (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 5, 2019 Category: Hematology Source Type: news

Good QOL, but Sexual Dysfunction Common After Prostate Cancer Good QOL, but Sexual Dysfunction Common After Prostate Cancer
Prostate cancer survivors can expect a similar quality of life as men in the general population, but sexual dysfunction after treatment is very common.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 5, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

GSK acquires rights to new Merck cancer treatment
UK group to pay up to €3.7bn to co-develop novel class of immunology (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - February 5, 2019 Category: Pharmaceuticals Source Type: news

USPSTF Still Recommends Against Pancreatic Cancer Screening
TUESDAY, Feb. 5, 2019 -- The U.S. Preventive Services Task Force (USPSTF) recommends against screening for pancreatic cancer in asymptomatic adults. These findings form the basis of a draft recommendation statement published online Feb. 5 by the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 5, 2019 Category: Pharmaceuticals Source Type: news

In survey, PhRMA member companies highlight impact of IPI on R & D
One of the biggest myths regarding the administration ’s proposed International Pricing Index (IPI) Model is that it will have little to no effect on biomedical research and development (R&D). Secretary of Health and Human ServicesAlex Azar has said that the reduction in R&D couldn ’t possibly be more than 1 percent. In contrast, PhRMA estimates that the impact of the model on R&D is much greater with a disproportionately negative effect on innovative medicines, including new medicines that are meeting unmet medical needs for previously untreatable conditions, like some cancers and potential cures f...
Source: The Catalyst - February 5, 2019 Category: Pharmaceuticals Authors: Katie Verb Tags: Research and Investment Part B Source Type: news

Elekta reports 1st treatment at Froedtert Hospital
Radiation oncology firm Elekta said the Clinical Cancer Center at Froedtert...Read more on AuntMinnie.comRelated Reading: Elekta initiates study on MR radiation therapy for cancer FDA clears Elekta's Unity MR radiation therapy system Elekta highlights Unity abstracts at ASTRO Elekta acquires software firm Acumyn Elekta, Philips bring MR-linac to Wis. (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 5, 2019 Category: Radiology Source Type: news

Moxibustion is an effective alternative cancer treatment, according to study
(Natural News) When people think of traditional Chinese medicine (TCM), one of the things that come to mind is acupuncture and herbs. However, a study published in the African Journal of Traditional, Complementary and Alternative Medicines looked at the benefits of moxibustion and its potential to prevent cell death and decrease the likelihood of gastric dysplasia — a condition... (Source: NaturalNews.com)
Source: NaturalNews.com - February 5, 2019 Category: Consumer Health News Source Type: news

GSK, Merck partner up to develop cancer immunotherapy in $4.2 billion deal
This global strategic alliance will see the two drugmakers jointly develop and commercialize bintrafusp alfa, an investigational bifunctional fusion protein immunotherapy that is currently in clinical development for multiple difficult-to-treat cancers (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - February 5, 2019 Category: Pharmaceuticals Source Type: news

Varian to present mobile app at HIMSS 2019
Radiation oncology firm Varian Medical Systems will showcase Varian Mobile,...Read more on AuntMinnie.comRelated Reading: Varian CEO rings NYSE opening bell on World Cancer Day Varian posts Q1 revenue gains 1st Taiwanese patients treated with Varian HyperArc Varian gets Chinese trade tariff exemption Varian gets China OK for Halcyon system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 5, 2019 Category: Radiology Source Type: news

Country star Doug Supernaw reveals he is battling stage IV lung and bladder cancer
Country music star Doug Supernaw, 58, was first diagnosed with pneumonia after a persistent cough until further tests revealed cancerous tumors in his lungs, lymph nodes, bones, and bladder (Source: the Mail online | Health)
Source: the Mail online | Health - February 5, 2019 Category: Consumer Health News Source Type: news

Boulder biotech firm's skin cancer drugs drive 'strong' second quarter
There were 2,600 new prescriptions of the cancer-fighting drug combo during the quarter. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 5, 2019 Category: Pharmaceuticals Authors: Andrew Dodson Source Type: news

Outcomes Good for Autologous Reconstruction After Implant Fail
Autologous breast reconstruction associated with improved patient satisfaction, quality of life (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 5, 2019 Category: Cancer & Oncology Tags: Gynecology, Oncology, Journal, Source Type: news

No Increased Risk for Cancer for ART - Conceived Children
Slightly but not significantly increased risks seen in children conceived by ICSI or cryopreservation (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 5, 2019 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pediatrics, Journal, Source Type: news

Roche wins speedy FDA review to adapt breast cancer med
The FDA will be reviewing Kadcyla under its Real-Time Oncology Review and Assessment Aid pilot program (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - February 5, 2019 Category: Pharmaceuticals Source Type: news

Cellect Biotechnology launches U.S. clinical trial
Cellect Biotechnology (NSDQ:APOP) said it is collaborating with Washington University on a study of its ApoGraft stem cell selection technology for bone marrow transplantations. This will be the first clinical trial in the U.S. using Tel Aviv, Israel-based Cellect’s ApoGraft, which is designed to prevent acute graft-versus-host disease following bone marrow transplantation. The company previously reported positive safety and tolerability data from an ongoing trial that is being performed outside the U.S., and expects to report additional interim results during the first half of 2019. Get the full ...
Source: Mass Device - February 5, 2019 Category: Medical Devices Authors: Nancy Crotti Tags: Blog Business/Financial News Clinical Trials News Well Oncology Regenerative Medicine cellectbiotechnology Washington University School of Medicine Source Type: news

Prolonged sitting, watching TV may increase colorectal cancer risk
Sitting and watching TV for an extended time can increase the colorectal cancer risk for younger adults, a new study says. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 5, 2019 Category: Consumer Health News Source Type: news